The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury

Critical Care Medicine

Volumn 36, Issue 11, 2008, Pages 3024-3029

  Durão, Marcelino S ^a,b   Monte, Julio C M ^a,b   Batista, Marcelo C ^a,b   Oliveira, Moacir ^a   Iizuka, Ilson J ^a   Santos, Bento F ^a,b   Pereira, Virgilio G ^a   Cendoroglo, Miguel ^b   Santos, Oscar F P ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute kidney injury; Anticoagulation; Citrate; Continuous renal replacement therapy; Continuous venovenous hemodiafiltration; Hemodiafiltration

Indexed keywords

CALCIUM; CHLORIDE; CITRIC ACID; CREATININE; ELECTROLYTE; LACTIC ACID; UREA; ANTICOAGULANT AGENT;

ACIDEMIA; ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CALCIUM BLOOD LEVEL; CHLORIDE BLOOD LEVEL; COHORT ANALYSIS; CONTINUOUS HEMODIAFILTRATION; CREATININE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; FEMALE; FILTER; HOSPITAL DISCHARGE; HUMAN; HYPERCHLOREMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY INJURY; LACTATE BLOOD LEVEL; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; METABOLIC ALKALOSIS; METABOLIC REGULATION; MORTALITY; PH; PRIORITY JOURNAL; PRIVATE HOSPITAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SEPSIS; STONE FORMATION; SURVIVOR; TERTIARY HEALTH CARE; UREA BLOOD LEVEL; ACUTE KIDNEY FAILURE; BLOOD; HEMODIAFILTRATION; INTENSIVE CARE; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; CITRATES; COHORT STUDIES; FEMALE; HEMODIAFILTRATION; HUMANS; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; LIVER FAILURE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME;

EID: 56049101618     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31818b9100     Document Type: Article

References (43)

1. Hou SH, Bushinsky DA, Wish JB, et al: Hospital-acquired renal insufficiency: A prospective study. Am J Med 1983; 74:243-248
2. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936
3. Bellomo R, Kellum J, Ronco C: Acute renal failure: Time for consensus. Intensive Care Med 2001; 27:1685-1688
4. Uchino S: The epidemiology of acute renal failure in the world. Curr Opin Crit Care 2006; 12:538-543
5. Bagshaw SM, Uchino S, Bellomo R, et al: Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007; 2:431-439
6. Himmelfarb J: Continuous dialysis is not superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract Nephrol 2007; 3:120-121
7. Ronco C: Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract Neph-rol 2007; 3:118-119
8. Bell M, SWING, Granath F, et al: Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33:773-780
9. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int 1993; 41(Suppl):S237-S244
10. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38:976-981
11. Oudemans-van Straaten HM, Wester JP, de Pont AC, et al: Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive Care Med 2006; 32:188-202
12. Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network (AKIN): Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31
13. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266
14. Meier-Kriesche HU, Gitomer J, Finkel K, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29:748-752
15. Mehta RL: Anticoagulation for continuous renal replacement therapy. In: Critical Care Nephrology. Ronco C, Bellomo R (Eds). Netherlands, Kluwer Academic Publishers, 1998, pp 1199-1211
16. Mehta RL: Acid-base and electrolyte complications in CRRT (part three). Available online at: http://www.hdcn.com. Accessed October 14, 2002
17. Sasaki S, Gando S, Kobayashi S, et al: Predictors of mortality in patients treated with continuous hemodiafiltration for acute renal failure in an intensive care setting. ASAIO J 2001; 47:86-91
18. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29:1910-1915
19. Bell M, Liljestam E, Granath F, et al: Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 2005; 20:354-360
20. Mehta RL, McDonald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163
21. Augustine JJ, Sandy D, Seifert TH, et al: A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44: 1000-1007
22. Morgera S, Kraft AK, Siebert G, et al: Long- term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002; 40:275-279
23. Manns B, Doig CJ, Lee H, et al: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 2003; 31:449-455
24. Guerin C, Girard R, Selli JM, et al: Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey. Intensive Care Med 2002; 28:1411-1418
25. Wald R, Deshpande R, Bell CM, et al: Survival to discharge among patients treated with continuous renal replacement therapy. Hemodial Int 2006; 10:82-87
26. Paganini EP, Tapolyai M, Goormastic M, et al: Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996; 28(Suppl 3):S81-S89
27. Schiffl H, Lang SM, Fischer R: Daily hemo-dialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-310
28. Storck M, Hartl WH, Zimmerer E, et al: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991; 337: 452-455
29. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
30. Saudan P, Niederberger M, De Seigneux S, et al: Adding a dialysis dose to continuous he-mofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70:1312-1317
31. Evanson JA, Himmelfarb J, Wingard R, et al: Prescribed versus delivered dialysis in acute renal failure patients. Am J Kidney Dis 1998; 32:731-738
32. Overberger P, Pesacreta M, Palevsky PM; VA/ NIH Acute Renal Failure Trial Network: Management of renal replacement therapy in acute kidney injury: A survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007; 2:623-630
33. Bagshaw SM, Laupland KB, Boiteau PJ, et al: Is regional citrate superior to systemic hep-arin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005; 20:155-161
34. Tolwani AJ, Prendergast MB, Speer RR, et al: A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1:79-87
35. Kutsogiannis DJ, Mayers I, Chin WD, et al: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35:802-811
36. Palsson R, Niles JL: Regional citrate antico-agulation in continuous venovenous hemo-filtration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-1997
37. Gabutti L, Marone C, Colucci G, et al: Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge. Intensive Care Med 2002; 28:1419-1425
38. Monchi M, Berghmans D, Ledoux D, et al: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30:260-265
39. Kutsogiannis DJ, Gibney RT, Stollery D, et al: Regional citrate versus systemic heparin an-ticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367
40. Joannidis M, Oudemans-van Straaten HM: Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11:218
41. Kramer L, Bauer E, Joukhadar C, et al: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31:2450-2455
42. Hetzel GR, Taskaya G, Sucker C, et al: Citrate plasma levels in patients under regional an-ticoagulation in continuous venovenous he-mofiltration. Am J Kidney Dis 2006; 48: 806-811
43. Swartz R, Pasko D, O'Toole J, et al: Improving the delivery of continuous renal replacement therapy using regional citrate antico-agulation. Clin Nephrol 2004; 61:134-143